![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
E Chu, GM Lai, S Zinn and CJ Allegra
Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland 20892.
Two human ovarian cancer cell lines were established from a patient before (PEO1) and after (PEO4) the onset of resistance to 5- fluorouracil (5-FU)/cisplatin-based chemotherapy. Using growth inhibition assays, we determined that the PEO4 line was almost 5-fold more resistant to 5-FU than the PEO1 line. The addition of either 1 or 20 microM leucovorin did not enhance the growth-inhibitory effects of 5- FU against the resistant PEO4 line. In characterizing the potential mechanisms of 5-FU resistance, we found no differences in thymidylate synthase activity between the two lines using both the 5-fluoro-2'- deoxyuridine-5'-monophosphate-binding and catalytic assays. A 4-hr exposure to 1 microM 5-FU resulted in greater ternary complex formation in the resistant line, and we observed no differences between the two lines in 5-FU incorporation into RNA. However, a 4-hr exposure to 1 microM [3H]5-FU resulted in a 3-fold decrease in 5-FU accumulation in the DNA of the resistant PEO4 line. Cesium sulfate gradient centrifugation was used to more accurately separate and analyze for DNA- incorporated 5-FU metabolites and confirmed that the absolute level of 5-FU in the DNA of the PEO4 cells was markedly decreased (6.5-fold) compared with that of the sensitive PEO1 cell line. Moreover, time course studies demonstrated that the accumulated 5-FU in the DNA of the PEO4 cells was more rapidly removed compared with that in the PEO1 cells. Our findings suggest that decreased 5-FU levels in DNA, in part due to an enhanced removal from DNA, represent a mechanism by which the human ovarian cancer PEO4 line expresses decreased sensitivity to 5-FU.
This article has been cited by other articles:
|
|
 |
|
  X. Lin, J. Liu, F. Maley, and E. Chu Role of cysteine amino acid residues on the RNA binding activity of human thymidylate synthase Nucleic Acids Res., August 15, 2003; 31(16): 4882 - 4887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. O. Wood, M. J. Dinsmore, G. A. Bare, and J. S. Lee M-DNA is stabilised in G*C tracts or by incorporation of 5-fluorouracil Nucleic Acids Res., May 15, 2002; 30(10): 2244 - 2250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Stevenson, W. P. Collins, F. Farzaneh, K. Hata, and K. Miyazaki Thymidine Phosphorylase Activity and Prodrug Effects in a Three-Dimensional Model of Angiogenesis : Implications for the Treatment of Ovarian Cancer Am. J. Pathol., November 1, 1998; 153(5): 1573 - 1578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Schwartz, N. Baptiste, S. Wadler, and D. Makower Thymidine Phosphorylase Mediates the Sensitivity of Human Colon Carcinoma Cells to 5-Fluorouracil J. Biol. Chem., August 11, 1995; 270(32): 19073 - 19077. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
